AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
TELMISARTAN BP
4 registrations across 3 African markets— 3 active
Markets with TELMISARTAN BP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| T-Sar Tablet 40mg Tablets | 🇷🇼Rwanda | CCL Pharmaceuticals (Pvt.) Ltd | active | Aug 2029 |
| ZYTEL 40 Tablet | 🇰🇪Kenya | M/S Cadila Healthcare Limited | active | Mar 2028 |
| ZYTEL 80 Tablet | 🇰🇪Kenya | M/S Cadila Healthcare Limited | active | Mar 2028 |
| ARBITEL_80 80MG UNCOATED TABLETS UNCOATED TABLETS | 🇲🇼Malawi | — | expired | Mar 2025 |
TELMISARTAN BP in Africa — Regulatory Overview
TELMISARTAN BP is registered across 3 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Malawi, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 3 (75%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.